About Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome is a rare disease catalogued by Orphanet (ORPHA:85112). It is associated with the RSPO1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome trials.
Search ClinicalTrials.gov for "Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome" or filter by Orphanet code ORPHA:85112 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome. Updated daily.